136 related articles for article (PubMed ID: 9657198)
21. Inhibition of protein geranylgeranylation causes a superinduction of nitric-oxide synthase-2 by interleukin-1beta in vascular smooth muscle cells.
Finder JD; Litz JL; Blaskovich MA; McGuire TF; Qian Y; Hamilton AD; Davies P; Sebti SM
J Biol Chem; 1997 May; 272(21):13484-8. PubMed ID: 9153192
[TBL] [Abstract][Full Text] [Related]
22. Protein geranylgeranylation is critical for the regulation of survival and proliferation of lymphoma tumor cells.
van de Donk NW; Schotte D; Kamphuis MM; van Marion AM; van Kessel B; Bloem AC; Lokhorst HM
Clin Cancer Res; 2003 Nov; 9(15):5735-48. PubMed ID: 14654559
[TBL] [Abstract][Full Text] [Related]
23. Antitumor efficacy of a novel class of non-thiol-containing peptidomimetic inhibitors of farnesyltransferase and geranylgeranyltransferase I: combination therapy with the cytotoxic agents cisplatin, Taxol, and gemcitabine.
Sun J; Blaskovich MA; Knowles D; Qian Y; Ohkanda J; Bailey RD; Hamilton AD; Sebti SM
Cancer Res; 1999 Oct; 59(19):4919-26. PubMed ID: 10519405
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of transendothelial migration and invasion of human breast cancer cells by preventing geranylgeranylation of Rho.
Kusama T; Mukai M; Tatsuta M; Nakamura H; Inoue M
Int J Oncol; 2006 Jul; 29(1):217-23. PubMed ID: 16773203
[TBL] [Abstract][Full Text] [Related]
25. Growth inhibition of astrocytoma cells by farnesyl transferase inhibitors is mediated by a combination of anti-proliferative, pro-apoptotic and anti-angiogenic effects.
Feldkamp MM; Lau N; Guha A
Oncogene; 1999 Dec; 18(52):7514-26. PubMed ID: 10602510
[TBL] [Abstract][Full Text] [Related]
26. Protein geranylgeranylation is required for osteoclast formation, function, and survival: inhibition by bisphosphonates and GGTI-298.
Coxon FP; Helfrich MH; Van't Hof R; Sebti S; Ralston SH; Hamilton A; Rogers MJ
J Bone Miner Res; 2000 Aug; 15(8):1467-76. PubMed ID: 10934645
[TBL] [Abstract][Full Text] [Related]
27. Protein isoprenylation regulates secretion of matrix metalloproteinase 1 from rheumatoid synovial fibroblasts: effects of statins and farnesyl and geranylgeranyl transferase inhibitors.
Abeles AM; Marjanovic N; Park J; Attur M; Chan ES; Al-Mussawir HE; Dave M; Fisher MC; Stuchin SA; Abramson SB; Pillinger MH
Arthritis Rheum; 2007 Sep; 56(9):2840-53. PubMed ID: 17763406
[TBL] [Abstract][Full Text] [Related]
28. The efficacy of tamoxifen as an antiproliferative agent in vitro for benign and malignant pediatric glial tumors.
Pollack IF; Kawecki S
Pediatr Neurosurg; 1995; 22(6):281-8. PubMed ID: 7577661
[TBL] [Abstract][Full Text] [Related]
29. Arglabin-DMA, a plant derived sesquiterpene, inhibits farnesyltransferase.
Shaikenov TE; Adekenov SM; Williams RM; Prashad N; Baker FL; Madden TL; Newman R
Oncol Rep; 2001; 8(1):173-9. PubMed ID: 11115593
[TBL] [Abstract][Full Text] [Related]
30. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
31. Endothelial protective genes induced by statin are mimicked by ERK5 activation as triggered by a drug combination of FTI-277 and GGTI-298.
Chu UB; Duellman T; Weaver SJ; Tao Y; Yang J
Biochim Biophys Acta; 2015 Jul; 1850(7):1415-25. PubMed ID: 25829196
[TBL] [Abstract][Full Text] [Related]
32. Effect of inhibition of farnesylation and geranylgeranylation on renal fibrogenesis in vitro.
Masterson R; Kelynack K; Hewitson T; Becker G
Nephron Exp Nephrol; 2006; 102(1):e19-29. PubMed ID: 16179803
[TBL] [Abstract][Full Text] [Related]
33. Role of RhoA activation in the growth and morphology of a murine prostate tumor cell line.
Ghosh PM; Ghosh-Choudhury N; Moyer ML; Mott GE; Thomas CA; Foster BA; Greenberg NM; Kreisberg JI
Oncogene; 1999 Jul; 18(28):4120-30. PubMed ID: 10435593
[TBL] [Abstract][Full Text] [Related]
34. Recent progress in developing small molecule inhibitors designed to interfere with ras membrane association: toward inhibiting K-Ras and N-Ras functions.
Tamanoi F; Lu J
Enzymes; 2013; 34 Pt. B():181-200. PubMed ID: 25034105
[TBL] [Abstract][Full Text] [Related]
35. Role for protein geranylgeranylation in adult T-cell leukemia cell survival.
Nonaka M; Uota S; Saitoh Y; Takahashi M; Sugimoto H; Amet T; Arai A; Miura O; Yamamoto N; Yamaoka S
Exp Cell Res; 2009 Jan; 315(2):141-50. PubMed ID: 18992741
[TBL] [Abstract][Full Text] [Related]
36. Protein kinase C inhibition by UCN-01 induces apoptosis in human glioma cells in a time-dependent fashion.
Bredel M; Pollack IF; Freund JM; Rusnak J; Lazo JS
J Neurooncol; 1999 Jan; 41(1):9-20. PubMed ID: 10222418
[TBL] [Abstract][Full Text] [Related]
37. Induction of parathyroid hormone-related peptide by the Ras oncogene: role of Ras farnesylation inhibitors as potential therapeutic agents for hypercalcemia of malignancy.
Aklilu F; Park M; Goltzman D; Rabbani SA
Cancer Res; 1997 Oct; 57(20):4517-22. PubMed ID: 9377563
[TBL] [Abstract][Full Text] [Related]
38. Protein isoprenylation regulates osteogenic differentiation of mesenchymal stem cells: effect of alendronate, and farnesyl and geranylgeranyl transferase inhibitors.
Duque G; Vidal C; Rivas D
Br J Pharmacol; 2011 Mar; 162(5):1109-18. PubMed ID: 21077849
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of GGTase-I and FTase disrupts cytoskeletal organization of human PC-3 prostate cancer cells.
Virtanen SS; Sandholm J; Yegutkin G; Kalervo Väänänen H; Härkönen PL
Cell Biol Int; 2010 Aug; 34(8):815-26. PubMed ID: 20446922
[TBL] [Abstract][Full Text] [Related]
40. Role for RhoB and PRK in the suppression of epithelial cell transformation by farnesyltransferase inhibitors.
Zeng PY; Rane N; Du W; Chintapalli J; Prendergast GC
Oncogene; 2003 Feb; 22(8):1124-34. PubMed ID: 12606940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
